THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Putting sleep ads to bed

With slowdown in demand, rise in generics, Sepracor scales back its push for Lunesta

By Todd Wallack
Globe Staff / October 6, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The once ubiquitous Lunesta luna moth is becoming harder to spot. Sepracor Corp., the Marlborough drug company that has flooded the airwaves for years with ads promoting its Lunesta sleep aid, has started to cut back on consumer advertising as the insomnia market slows, rivals cut back on their own marketing, and Sepracor shifts its promotional budget to products that ... (Full article: 758 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass